BCL2 and cancer: Although miR‐365 has been shown to repress bcl‐2 expression in cancer cells and human umbilical vein endothelial cells (HUVECs; Nie et al., 2012; Qin et al., 2011), we still need to determine whether miR‐365 would modulate bcl‐2 expression in adult rat brain after ischemic stroke.